Unpacking the Testosterone Lawsuits: A Closer Look at AbbVie and AndroGel

  https://www.medlegal360.com/testosterone-lawsuits/ As the global pandemic unfolded, a surge in internet usage for everything from retail therapy to prescription refills became the new norm. Amidst this digital influx, many men grappling with symptoms like mood swings, fatigue, and physical weakness sought medical answers online. Attracted by alluring advertisements, numerous men started using testosterone therapy as a panacea for their malaise. However, what many didn't realize was the therapy's primary purpose: treating hypogonadism, a condition far removed from pandemic-induced stress or aging. Beginning in 2014, a slew of testosterone lawsuits targeted testosterone producers, with AbbVie bearing the brunt. Its product, AndroGel, found itself embroiled in allegations of inducing heart attacks. Of over 7,000 lawsuits related to testosterone replacement medications, approximately 4,500 were directed against AndroGel. Yet, AbbVie wasn't alone; other pharmaceutical gia...